<< Back to Results
14T-MC-JVBA - Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab vs. Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression After One Platinum-Based Therapy. Accrual limited to Abington Cancer Care Specialists.
Clinical Trial Categories
- The Rosenfeld Cancer Center at 215-481-2402
- The Rosenfeld Cancer Center